Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
Activation of Ghrelin receptors have been demonstrated to stimulate appetite. RC-1291 HCl, by
virtue of its ghrelin like activity and Growth Hormone releasing effects may have a dual role
in the reversal of cancer induced anorexia and cachexia. This placebo controlled study will
evaluate the safety and efficacy of RC-1291 HCl in cancer patients with cachexia.